logo

Melinta Therapeutics, Inc (MLNT)



Trade MLNT now with
  Date
  Headline
12/27/2019 9:04:56 AM Melinta Therapeutics Initiates Voluntary Chapter 11 Process To Effectuate Restructuring Transaction
9/3/2019 4:08:26 PM Melinta Therapeutics Appoints Jennifer Sanfilippo As Interim CEO And Director
8/9/2019 7:33:39 AM Melinta Therapeutics Names David Gill Chairman Of Board
7/16/2019 7:35:23 AM Melinta Therapeutics Expects Q2 Net Product Sales Of About $13.8 Mln
6/19/2019 7:43:52 AM Melinta Therapeutics Announces FDA Acceptance Of SNDA For BAXDELA For Community-Acquired Bacterial Pneumonia
12/19/2018 8:37:13 AM Melinta Announces Commitment For New Credit Facility Of Up To $135 Mln
12/19/2018 8:35:53 AM John Johnson Agrees To Become Permanent CEO Of Melinta Therapeutics
12/17/2018 7:34:10 AM Dova Pharmaceuticals Names David Zaccardelli President And CEO
11/27/2018 8:06:54 AM Melinta Therapeutics Granted European Commission Marketing Authorization For Vabomere
11/7/2018 7:14:52 AM Melinta Therapeutics Q3 Net Loss $27.9 Mln Or $0.50/Shr
10/31/2018 5:20:06 PM Melinta Therapeutics Appoints Bruce Downey To Board Of Directors